diabetes-mellitus

Documents about diabetes-mellitus

• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin#160297ClinicalTrials.gov
• Dietary Intervention Modifies Gut Microbiota in Type 2 Diabetes.#162389ClinicalTrials.gov
• Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes#180358ClinicalTrials.gov
• Effects of Benfotiamine and AGE on Endothelial Function in People With Diabetes#181672ClinicalTrials.gov
• The Effect of Soliqua on Glucose Variability in Type 2 Patients Among South Asians#181680ClinicalTrials.gov
• Metformin in Co-morbid Diabetes or Prediabetes and Serious Mental Illness#184761ClinicalTrials.gov
• Efficacy of Amoxicillin-metronidazole Compared to Clindamycin in Patients With Periodontitis and Diabetes#184771ClinicalTrials.gov
• FinnDiane LifeOne Study - Impact of Ageing on People With Type 1 Diabetes#195494ClinicalTrials.gov
• Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin#195520ClinicalTrials.gov
• Glucagon Rescue of Insulin-Induced Hypoglycemia in Adults With Type 1 Diabetes Treated With Volagidemab#201682ClinicalTrials.gov
• A Randomised Trial Evaluating Continuous Subcutaneous Infusion of Formulations of NN1218 and NovoLog® in Subjects With Type 1 Diabetes#28496ClinicalTrials.gov
• A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes#127829ClinicalTrials.gov
• Comparison of the Change in Fat Distribution in Overweight and Obese Subjects With Type 2 Diabetes After Insulin Treatment#146403ClinicalTrials.gov
• Dynamically predicting renal failure after development of diabetes across biobanks#152683PLOS
• Capillary And Venous Accuracy: LifeScan Products vs Hospital Reference and YSI#18784ClinicalTrials.gov
• iGlarLixi vs IDegAsp in Chinese Participants After OAD(s)#28569ClinicalTrials.gov
• Feasibility of ECG-Based Glucose Monitoring System#121231ClinicalTrials.gov
• Glucose Reduction by Early Acarbose Treatment in Basal Insulin#123403ClinicalTrials.gov
• Bigfoot Biomedical Clinical Research Center (CRC) Trial#126007ClinicalTrials.gov
• GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin#126053ClinicalTrials.gov
• Acetylcarnitine and Insulin Sensitivity#143712ClinicalTrials.gov
• Glimepiride, Alogliptin and Alogliptin+Pioglitazone Combination#152351ClinicalTrials.gov
• Resistant Hypertension in Patients With Type-II-Diabetes Mellitus#160240ClinicalTrials.gov
• Fenofibrate Versus Curcumin in Type 2 Diabetic Patients#160243ClinicalTrials.gov
• Study Evaluating Rimonabant Efficacy in Drug-NAive DiabEtic Patients#160270ClinicalTrials.gov
• IL-1RA, Acute Exercise, and Beta-cell Function#160282ClinicalTrials.gov
• Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study#191576ClinicalTrials.gov
• Insulin Secretion and Advagraf#195492ClinicalTrials.gov
• Regulatory Post Marketing Surveillance (rPMS) Study of Rybelsus (Oral Semaglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea#136217ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin#180335ClinicalTrials.gov
• A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients#184783ClinicalTrials.gov
• Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin#184793ClinicalTrials.gov
• Comparison of Two NN1250 Formulations Versus Insulin Glargine, All in Combination With Insulin Aspart in Subjects With Type 1 Diabetes#18816ClinicalTrials.gov
• The Effect of Mobile Application Supported Diabetes Education On Type 2 Diabetes Self-Management And Blood Sugar Level#152571ClinicalTrials.gov
• A Trial Comparing Efficacy and Safety of Insulin Degludec and Insulin Glargine in Insulin naïve Subjects With Type 2 Diabetes#158191ClinicalTrials.gov
• Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens#180336ClinicalTrials.gov
• Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study#7095OpenAlex
• Efficacy and Safety of BI 1356 BS (Linagliptin) in Combination With Metformin in Patients With type2 Diabetes#28550ClinicalTrials.gov
• Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes#67762ClinicalTrials.gov
• Diabetes, Lipoproteins and Accelerated Vascular Disease#121274ClinicalTrials.gov
• Autoimmunity-blocking Antibody for Tolerance in Recently Diagnosed Type 1 Diabetes#123638ClinicalTrials.gov
• Diabetes Effects on Long-Term Implant Survival and Success#126006ClinicalTrials.gov
• A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients#126076ClinicalTrials.gov
• Comparison of Pioglitazone Versus Glimepiride in Type 2 Diabetes Inadequately Controlled With Metformin Plus Alogliptin#126077ClinicalTrials.gov
• To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin.#127761ClinicalTrials.gov
• A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients#136229ClinicalTrials.gov
• Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy#136268ClinicalTrials.gov
• A Study of LY2963016 Compared to Lantus® in Adult Chinese Participants With Type 1 Diabetes Mellitus#136274ClinicalTrials.gov
• Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin Treatment#136280ClinicalTrials.gov
• Multiple Dose Study of MK-2828 in Participants With Type 2 Diabetes (MK-2828-003)#141186ClinicalTrials.gov